(Q36317067)

13 August 2017

1 reference

title

Pharmacologic advances in the systemic treatment of itch (English)

1 reference

13 August 2017

Brett T Summey

1

1 reference

13 August 2017

Gil Yosipovitch

series ordinal

2

1 reference

13 August 2017

publication date

1 July 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

18

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

328-332

1 reference

Pruritus-associated response mediated by cutaneous histamine H3 receptors

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Itch: scratching more than the surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Itch-scratch responses induced by opioids through central mu opioid receptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Relief of Intractable Pruritus With Naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Modern hair restoration surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Understanding pruritus in systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

21 January 2018

Mirtazapine for pruritus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Tolerability and safety aspects of mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Brachioradial pruritus: response to treatment with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Treatment of prurigo nodularis with thalidomide: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Neurophysiology of pruritus: cutaneous elicitation of itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2005.00035.X

10.1111/J.1529-8019.2005.00035.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference